Preventing Vision Loss: How Evoq Technologies is Changing Eye Health

In this episode of the Heals Las Vegas podcast, I had the pleasure of interviewing Daniel Lindgren, the founder of Evoq Technologies, a company focused on innovative ophthalmological devices for animals and humans. We explored Daniel's journey to Las Vegas, which began in 2014 when he moved here for his then-wife's pharmacy studies at Roseman University.

Daniel shared his extensive background in ophthalmic eye drug development and how his father's influence as a medical physicist and entrepreneur inspired him to pursue a career in medical technology. We discussed the importance of early detection of retinal diseases, which affect millions of people in the U.S., particularly those with diabetes and age-related macular degeneration.

One of the key highlights of our conversation was the introduction of Evoq's groundbreaking device, the Twilight dark adaptometer. This portable and user-friendly tool allows for the assessment of dark adaptation, a critical function of the retina that can indicate potential vision problems before structural damage occurs. Daniel emphasized the significance of early intervention and lifestyle changes in preserving vision, noting that many eye issues are preventable.

We also touched on the broader implications of Daniel's work, particularly in addressing the growing demand for eye care amidst a shortage of specialists. By making advanced diagnostic tools accessible to primary care providers and potentially even to patients at home, Evoq Technologies aims to revolutionize how we approach eye health.

Overall, this episode sheds light on the intersection of technology and healthcare, highlighting the potential for innovation to improve patient outcomes and access to care in the field of ophthalmology.